Screener
Regeneron Pharmaceuticals REGN Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Regeneron Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
FAQ
- What is Regeneron Pharmaceuticals's price / sales?
- Regeneron Pharmaceuticals (REGN) reported price / sales of 4.2× in Q2 2026.
- How has Regeneron Pharmaceuticals's price / sales changed year-over-year?
- Regeneron Pharmaceuticals's price / sales increased by 6.1% year-over-year, from 4× to 4.2×.
- What is the long-term trend for Regeneron Pharmaceuticals's price / sales?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's price / sales has grown at a -1.5% compound annual growth rate (CAGR), from 6.1× to 5.7×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Regeneron Pharmaceuticals's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude